Other
Drug Facts
No-weak-nails Tablet
FDA Label NDC 59672-0916
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Miers Laboratories for the product No-weak-nails (NDC 59672-0916). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, active ingredients, purpose, uses, otc - do not use, otc - ask doctor, otc - stop use, otc - pregnancy or breast feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Active Ingredients
Graphite 30C HPUS
Thuja Occi 30C HPUS
Silicon Dioxide 30C HPUS
The letters HPUS indicate that these ingredients are officially included in the Homeopathic Pharmacopeia of the United States.
Purpose
To improve nails
Uses
Improves the strength and appearance of finger nails
Otc - Do Not Use
Do not use if the blister pack is broken.
Otc - Ask Doctor
Ask a doctor before use in children under 2 years of age.
Otc - Stop Use
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen.
Otc - Pregnancy Or Breast Feeding
If pregnant or breast-feeding, ask a health professional before use.
Otc - Keep Out Of Reach Of Children
Keep out of reach of children.
Directions
| Age | Dose |
|---|---|
| Adults and Children 2 years and over | Chew two tablets four times a day for two days until all taken. |
| Under 2 years | Ask a doctor. |
Other Information
- Store under 86°F (30°C)
- No drug interactions
- Non-drowsy
Inactive Ingredients
Dextrose and separating agents magnesium stearate and silicon dioxide
Principal Display Panel - 16 Tablet Blister Pack Carton
NDC 59672-0916-1
HOMEOPATHIC
WEAK NAILS PREVENTION
NO-WEAK-NAILS
Net 16 Tablets
Principal Display Panel (16 Tablet Blister Pack Carton)
* Please review the disclaimer below.
